CaNCURE Mentors


Anna Moore, Ph.D.


Professor of Radiology
Harvard Medical School




amoore@helix.mgh.harvard.edu

Biography: Anna Moore, PhD, is a Professor of Radiology at Massachusetts General Hospital and Harvard Medical School where she directs the Molecular Imaging Laboratory in the Department of Radiology. She received her Ph.D. degree in Bioorganic Chemistry from Russian Academy of Sciences. She began a postdoctoral fellowship at the Center for Molecular Imaging Research (Department of Radiology, MGH) in 1991 with Dr. Ralph Weissleder. During her fellowship, Dr. Moore began to develop molecular imaging theranostic agents, first for cancer and then for diabetes. She has served as a Member of the Affiliated Faculty of Harvard-MIT Division of Health Sciences and Technology (HST). Dr. Moore has an exceptional track record of supervising trainees, with many of these have gone on to very successful research careers. For her contribution to teaching courses at international meetings she was awarded with the “Outstanding Teacher Award” from the International Society for Magnetic Resonance in Medicine in 2008. She was awarded a Distinguished Investigator Award from the Academy of Radiology Research in 2014. She is a standing member on the NIH CMIP Study Section and a reviewer for over 30 journals. Uniquely, Dr. Moore was elected twice as a Chair of the Cellular and Molecular Imaging study group at the International Society for Magnetic Resonance in Medicine (ISMRM)

Research and Expertise: Dr. Moore’s research interests are directed at development and use of in vivo molecular imaging technologies as indispensable preclinical and clinical tools that will allow us to unravel complex biological pathways and mechanisms of pathogenesis. Her interdisciplinary research has led to the development of multimodal imaging tools with broad utility across disciplines. Dr. Moore first developed theranostic nanodrugs and other tools for the detection and treatment of cancer, and then was the first to recognize their utility for the study and treatment of diabetes. Her research in cancer imaging and therapy leads the field with significant advances in theranostics, where she has developed technologies that can both diagnose and treat cancer. She applied these technologies to type 1 (juvenile) diabetes where imaging is crucial for detection, diagnosis, prognosis and guided therapeutics. Dr. Moore established the field of imaging and image-guided therapy of the diabetic pancreas and pancreatic adenocarcinoma, and continues as a leader in this area

Website

Publications


Featured Publications

NanomedicinePhD

nanophores

SiRNA nanocomplexes